Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
World
Storm Newton

Daily pill for lung cancer to be made routinely available on the NHS

Osimertinib can help stop cancer from returning after surgery when taken alongside chemotherapy (Rui Vieira/PA) - (PA Archive)

A daily pill that has shown to double survival time in certain lung cancer patients is to be made routinely available on the NHS, with hundreds of people set to benefit.

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery when taken alongside chemotherapy.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.